Skip to NavigationSkip to content

Ergomed announces board changes

Published on: 19/01/16

Ergomed, a specialist provider of drug development services to the pharmaceutical industry, has announced that Neil Clark, current chief financial officer, has been appointed as full time chief executive of PrimeVigilance.

PrimeVigilance is Ergomed’s trading subsidiary, and a leading provider of drug safety and medical information services to the pharma and biotech industry. 

As a consequence of this change, the Ergomed board also announced that Stephen Stamp has been appointed as new chief financial officer and will join the Ergomed board of directors immediately. Clark remains an Ergomed Board member. 

Stamp brings to Ergomed more than 30 years of experience in corporate finance and general management in both public and private companies in the UK and the USA. He joins the company from US-based AssureRx Health, a personalised medicine and bio-informatics company, where he held the same position. 

A former investment banker, Stamp has substantial experience working in UK-listed companies, including his time as group finance director at Regus and as group finance director at Shire Pharmaceuticals, where he led the IPO on London Stock Exchange as well as a number of major acquisitions and financings.

Dr Miroslav Reljanovic, founder and chief executive of Ergomed, says: “We are pleased to strengthen the board and I welcome Stephen to Ergomed as our new chief financial officer. He brings significant experience and a track record of delivery in senior financial roles in the pharmaceutical industry. At the same time, we will continue to benefit from Neil’s continued commitment to the Group as he takes over as full time CEO at PrimeVigilance. 

“PrimeVigilance has grown into one of the leading European pharmacovigilance companies within five years and is a key growth driver for Ergomed. Neil’s leadership will enable us to expand and further strengthen our presence in the fast growing pharmaceutical post-marketing services sector.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches